AU2003298664A1 - Treatment of cognitive dysfunctions' - Google Patents

Treatment of cognitive dysfunctions'

Info

Publication number
AU2003298664A1
AU2003298664A1 AU2003298664A AU2003298664A AU2003298664A1 AU 2003298664 A1 AU2003298664 A1 AU 2003298664A1 AU 2003298664 A AU2003298664 A AU 2003298664A AU 2003298664 A AU2003298664 A AU 2003298664A AU 2003298664 A1 AU2003298664 A1 AU 2003298664A1
Authority
AU
Australia
Prior art keywords
treatment
cognitive dysfunctions
dysfunctions
cognitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003298664A
Other versions
AU2003298664A8 (en
Inventor
Jay D. Kranzler
Srinivas G. Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cypress Bioscience Inc
Original Assignee
Cypress Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cypress Bioscience Inc filed Critical Cypress Bioscience Inc
Publication of AU2003298664A8 publication Critical patent/AU2003298664A8/en
Publication of AU2003298664A1 publication Critical patent/AU2003298664A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
AU2003298664A 2002-11-20 2003-11-18 Treatment of cognitive dysfunctions' Abandoned AU2003298664A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US42776702P 2002-11-20 2002-11-20
US60/427,767 2002-11-20
US44314203P 2003-01-28 2003-01-28
US60/443,142 2003-01-28
US47976103P 2003-06-18 2003-06-18
US60/479,761 2003-06-18
PCT/US2003/036813 WO2004045718A2 (en) 2002-11-20 2003-11-18 Treatment of cognitive dysfunctions'

Publications (2)

Publication Number Publication Date
AU2003298664A8 AU2003298664A8 (en) 2004-06-15
AU2003298664A1 true AU2003298664A1 (en) 2004-06-15

Family

ID=32329863

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003298664A Abandoned AU2003298664A1 (en) 2002-11-20 2003-11-18 Treatment of cognitive dysfunctions'

Country Status (2)

Country Link
AU (1) AU2003298664A1 (en)
WO (1) WO2004045718A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US20030232805A1 (en) * 2002-04-24 2003-12-18 Cypress Bioscience, Inc. Prevention and treatment of functional somatic disorders, including stress-related disorders
AR043467A1 (en) * 2003-03-05 2005-07-27 Osmotica Argentina S A DRUG COMBINATION FOR MOTOR DYSFUNCTION IN PARKINSON'S DISEASE
GB0309440D0 (en) * 2003-04-25 2003-06-04 Lilly Co Eli Quinolone derivatives
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
US20080058318A1 (en) * 2006-08-09 2008-03-06 Cypress Bioscience, Inc. Milnacipran for the treatment of cognitive dysfunction associated with fibromyalgia
GB0701970D0 (en) 2007-02-01 2007-03-14 Wilson Stuart Treatment of protein aggregation diseases
FR2978350B1 (en) 2011-07-28 2013-11-08 Pf Medicament LEVOMILNACIPRAN-BASED MEDICINAL PRODUCT FOR FUNCTIONAL REHABILITATION AFTER ACUTE NEUROLOGICAL ACCIDENT
WO2013166468A1 (en) * 2012-05-04 2013-11-07 Insero Health Inc. Compositions and methods for treating neurodegenerative diseases
US11957692B2 (en) 2022-05-23 2024-04-16 National Institute Of Immunology Clomipramine for the treatment of Alzheimer's Disease

Also Published As

Publication number Publication date
AU2003298664A8 (en) 2004-06-15
WO2004045718A2 (en) 2004-06-03
WO2004045718A3 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
AU2002257936A1 (en) Methods of well treatment
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2003283257A1 (en) Scalp treatment
AU2003268295A1 (en) "diagnosis and treatment of infertility"
AU2003298664A1 (en) Treatment of cognitive dysfunctions'
AU2002319286A1 (en) Skin treatment
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
AU2003268923A1 (en) Treatment of aml
EP1455780A4 (en) Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
AU2003219580A1 (en) Novel therapeutical use of byakangelicin
AU2003237657A1 (en) Means and methods for improved treatment using "setrones"
AU2002243883A1 (en) Cholesterol-lowering agents as treatment for psychological and cognitive disorders
AU2003231279A1 (en) Prevention and treatment of type 2 diabetes
AU2002363228A1 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
GB0101146D0 (en) Treatment of skin conditions
AU2003207315A1 (en) Treatment of muscle damage
GB0217493D0 (en) Novel methods of treatment
AU2002350053A1 (en) Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
AU2003237143A1 (en) Diagnosis and treatment of glaucoma
AU2003249364A8 (en) Algal gdp-mannose-3',5'-epimerases and methods of use thereof
AU2002361254A1 (en) Tracking early indicia of beauty treatment progress
GB0222015D0 (en) Means of assembly-bozz 2
AU2003299311A1 (en) Treatment of neuro-psychiatric disorders
AU2003271712A1 (en) Treatment of amm
GB0329357D0 (en) Treatment of materials

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase